Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Roberta Baltera, Stuart Collinson, Robert Millman

Premium

Arcturus Therapeutics has appointed Robert Baltera and Stuart Collinson to its board of directors.

Baltera previously served as CEO of Amira Pharmaceuticals, which was acquired by Bristol-Myers Squibb. Before that, he held various roles at Amgen. He is currently on the board of Organovo Holdings, Xencor, Panmira Pharmaceuticals, and San Diego Venture Group.

Collinson is a partner at investment firm Forward Ventures and is executive chairman of Tioga Pharmaceuticals. He previously was chairman, CEO, and president of Aurora Biosciences, which was acquired by Vertex. He has also held different senior management positions at GlaxoWellcome (now GlaxoSmithKline) and Baxter International.


Tauriga Sciences has appointed Robert Millman to its business advisory board.

Millman is currently a managing director at MPM Capital and previously was chief intellectual property counsel for Alnylam Pharmaceuticals.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.